Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Balance Sheet 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 383.5M | 323.1M | 322.6M | 344.5M | 304.4M | 159.2M |
| Cash & Equivalents | 111.0M | 71.6M | 67.4M | 122.0M | 67.3M | 37.6M |
| Liabilities | ||||||
| Total Liabilities | 369.8M | 352.7M | 329.4M | 299.3M | 209.1M | 125.4M |
| Long-Term Debt | 220.3M | 232.1M | 190.9M | 187.1M | 88.1M | 87.0M |
| Equity | ||||||
| Shareholders' Equity | 13.7M | -29.6M | -6.8M | 45.2M | 95.2M | 33.8M |
Xeris Biopharma Holdings, Inc. Balance Sheet — FAQ
Xeris Biopharma Holdings, Inc. (XERS) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's balance sheet history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s balance sheet by year and by quarter, including the growth rate.